We've found 3 total result s for "Common Variable Immunodeficiency".

Leniolisib for Immune Dysregulation in CVID

In this study, common variable immunodeficiency (CVID) patients will all receive the study drug, leniolisib, for a treatment period of 6 months. Participants will start on a lower dose of leniolisib, followed by a mid and then a higher dose level. The primary goal is...

Age: 12 - 75 years

Gender: All